Viewing Study NCT03818061


Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-01-10 @ 6:01 AM
Study NCT ID: NCT03818061
Status: UNKNOWN
Last Update Posted: 2023-09-28
First Post: 2019-01-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck
Sponsor: Centre Leon Berard
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module